The Effect of Punctal Plugs on Ocular Surface After Povidone-Iodine Preparation of Intravitreal Injection
The Effect of Punctal Plugs in Reducing Ocular Surface Irritation After Povidone-Iodine Preparation of Intravitreal Injection
1 other identifier
interventional
126
1 country
1
Brief Summary
The aim of this study is to evaluate the effectiveness of punctal plugs in reducing ocular surface (eye surface) irritation after intravitreal injections prepared by povidone-iodine 5% solution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2019
CompletedFirst Posted
Study publicly available on registry
May 10, 2019
CompletedStudy Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 18, 2020
CompletedDecember 7, 2023
November 1, 2023
1.4 years
February 10, 2019
November 30, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in ocular (eye) discomfort
Measure participants' level of discomfort after punctal plugs using the Ocular Surface Disease Index (OSDI), which is a paper survey that participants fill out based on their symptoms and level of ocular discomfort (if any).
From date of randomization until date of death from any cause, whichever came first, assessed up to 100 weeks
Study Arms (2)
Puntal plug
ACTIVE COMPARATORSubjects will receive temporary punctal plug after intravitreal injection
Non-Punctual plug
NO INTERVENTIONSubjects will not receive temporary punctal plug after intravitreal injection
Interventions
Punctal plug will be given to subjects after intravitreal injection in half of the study subjects
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of age-related macula degeneration
- Clinical diagnosis of diabetic retinopathy
- Clinical diagnosis of retinal vein occlusion
You may not qualify if:
- Currently wearing punctal plugs
- History of punctal cautery,
- Active ocular infection
- History of ocular infection
- Eyelid trauma
- Eyelid surgery
- Graft versus host disease
- Thyroid eye disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dean McGee Eye Institute
Oklahoma City, Oklahoma, 73104, United States
Related Publications (5)
Goldberg RA. How to prevent endophthalmitis after intravitreal injections. Int J Retina Vitreous. 2015 Aug 11;1:12. doi: 10.1186/s40942-015-0012-9. eCollection 2015.
PMID: 27847605BACKGROUNDLaude A, Lim JW, Srinagesh V, Tong L. The effect of intravitreal injections on dry eye, and proposed management strategies. Clin Ophthalmol. 2017 Aug 16;11:1491-1497. doi: 10.2147/OPTH.S136500. eCollection 2017.
PMID: 28860698BACKGROUNDMarcet MM, Shtein RM, Bradley EA, Deng SX, Meyer DR, Bilyk JR, Yen MT, Lee WB, Mawn LA. Safety and Efficacy of Lacrimal Drainage System Plugs for Dry Eye Syndrome: A Report by the American Academy of Ophthalmology. Ophthalmology. 2015 Aug;122(8):1681-7. doi: 10.1016/j.ophtha.2015.04.034. Epub 2015 May 30.
PMID: 26038339BACKGROUNDRidder WH 3rd, Oquindo C, Dhamdhere K, Burke J. Effect of Povidone Iodine 5% on the Cornea, Vision, and Subjective Comfort. Optom Vis Sci. 2017 Jul;94(7):732-741. doi: 10.1097/OPX.0000000000001091.
PMID: 28609415BACKGROUNDSaedon H, Nosek J, Phillips J, Narendran N, Yang YC. Ocular surface effects of repeated application of povidone iodine in patients receiving frequent intravitreal injections. Cutan Ocul Toxicol. 2017 Dec;36(4):343-346. doi: 10.1080/15569527.2017.1291665. Epub 2017 Feb 28.
PMID: 28166657BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vinay Shah, MD
University of Oklahoma
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2019
First Posted
May 10, 2019
Study Start
June 1, 2019
Primary Completion
October 18, 2020
Study Completion
October 18, 2020
Last Updated
December 7, 2023
Record last verified: 2023-11